BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7258856)

  • 1. Quantitative analysis of the nuclear area variation in benign and malignant breast cytology specimens.
    Cornelisse CJ; de Koning HR; Arentz PW; Raatgever JW; van Heerde P
    Anal Quant Cytol; 1981 Jun; 3(2):128-34. PubMed ID: 7258856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of nuclear area variation in benign and malignant breast fine needle aspirates.
    Kaushik N; Sardana S; Das DK; Luthra UK
    Indian J Cancer; 1991 Dec; 28(4):202-7. PubMed ID: 1667921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The nuclear surface area as a malignancy parameter in breast cancer].
    Schöndorf H; Bastert G; Löbel M; Naujoks H
    Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):272-6. PubMed ID: 2721889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of mean nuclear area with estrogen receptor content in aspiration cytology of breast carcinoma.
    Mossler JA; McCarty KS; Woodard BH; Mitchener LM; Johnston WW
    Acta Cytol; 1982; 26(4):417-21. PubMed ID: 6957091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters.
    Sirotkovic-Skerlev M; Krizanac S; Kapitanovic S; Husnjak K; Unusic J; Pavelic K
    Exp Mol Pathol; 2005 Aug; 79(1):42-50. PubMed ID: 16005711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of DNA image cytometry for the cytological diagnosis of well-differentiated breast carcinomas and benign lesions.
    Seigneurin D; Louis J; Villoud MC
    Anal Cell Pathol; 1994 Aug; 7(2):115-25. PubMed ID: 7993822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic relevance of silver stained nucleolar organizer region (AgNORs) in benign and malignant breast lesions.
    Agarwal PK; Mehrotra A; Chandra T
    Indian J Exp Biol; 1995 Oct; 33(10):715-20. PubMed ID: 8575800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis.
    Abdalla F; Boder J; Markus R; Hashmi H; Buhmeida A; Collan Y
    Anticancer Res; 2009 May; 29(5):1771-6. PubMed ID: 19443402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear profiles of cancer cells reveal the metastatic potential of gastric cancer.
    Ikeguchi M; Cai J; Oka S; Gomyou Y; Tsujitani S; Maeta M; Kaibara N
    J Pathol; 2000 Sep; 192(1):19-25. PubMed ID: 10951395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of AgNORS in fine needle aspiration cytology of breast lesions.
    Rajeevan K; Aravindan KP; Kumari BC
    Indian J Pathol Microbiol; 1995 Jan; 38(1):17-24. PubMed ID: 8919465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of underlying characteristics of nuclear chromatin patterns of thyroid tumor cells using texture and factor analyses.
    Murata S; Mochizuki K; Nakazawa T; Kondo T; Nakamura N; Yamashita H; Urata Y; Ashihara T; Katoh R
    Cytometry; 2002 Nov; 49(3):91-5. PubMed ID: 12442308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear morphology in breast cancer: is pleomorphism an illusion?
    Huang J; Bay BH; Tan PH
    Med Hypotheses; 2000 Jul; 55(1):26-8. PubMed ID: 11021321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear morphometry for the prediction of regional lymph nodes metastases in patients with cancer of the larynx.
    Dobroś W; Gil K; Ryś J; Stanisz-Wallis K
    Otolaryngol Head Neck Surg; 2000 Dec; 123(6):770-4. PubMed ID: 11112977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear morphometry in FNABs of breast disease in Libyans.
    Abdalla F; Boder J; Buhmeida A; Hashmi H; Elzagheid A; Collan Y
    Anticancer Res; 2008; 28(6B):3985-9. PubMed ID: 19192660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
    Karbowniczek M; Chosia M; Domagała W
    Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer-generated nuclear features compared with axillary lymph node status and tumor size as indicators of breast cancer survival.
    Wolberg WH; Street WN
    Hum Pathol; 2002 Nov; 33(11):1086-91. PubMed ID: 12454812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear morphometry and glutathione S-transferase pi expression in breast cancer.
    Huang J; Bay BH; Tan PH
    Oncol Rep; 2000; 7(3):609-13. PubMed ID: 10767377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of argyrophylic nucleolar organiser regions (AgNORs) in breast lesions.
    Simha M; Menon M; Doctor V
    Indian J Cancer; 1996 Jun; 33(2):76-85. PubMed ID: 8979469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Texture image analysis in differentiating malignant from benign adrenal cortical tumors in children and adults.
    Shirata NK; Sredni ST; Castelo A; Santinelli A; Mendonça B; Montironi R; Filho AL; Zerbini MC
    Anticancer Res; 2009 Aug; 29(8):3365-8. PubMed ID: 19661357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels.
    Del Vecchio S; Stoppelli MP; Carriero MV; Fonti R; Massa O; Li PY; Botti G; Cerra M; D'Aiuto G; Esposito G
    Cancer Res; 1993 Jul; 53(13):3198-206. PubMed ID: 7686450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.